Insider Sale: Director at $MDGL (MDGL) Sells 520 Shares
Insider Sale: Director at $MDGL (MDGL) Sells 520 Shares
FRED B CRAVES, a director at $MDGL ($MDGL), sold 520 shares of the company on 12-03-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 4.5% of their shares. Following this trade, they now own 11,000 shares of $MDGL stock.
董事FRED b CRAVES在12-03-2024年卖出了公司的520股股票。我们从最近的SEC备案中获得了该交易的数据。这是他们持股约4.5%的出售。在此交易之后,他们现在拥有11,000股$MDGL股票。
$MDGL Insider Trading Activity
$MDGL内幕交易活动
$MDGL insiders have traded $MDGL stock on the open market 13 times in the past 6 months. Of those trades, 0 have been purchases and 13 have been sales.
$MDGL内部人士在过去6个月里已经进行了13次开放市场交易$MDGL股票。在这些交易中,有0次购买和13次出售。
Here's a breakdown of recent trading of $MDGL stock by insiders over the last 6 months:
以下是近6个月内部人士对$MDGL股票的最新交易:
- FRED B CRAVES has traded it 4 times. They made 0 purchases and 4 sales, selling 7,000 shares.
- CAROLE HUNTSMAN (Chief Commercial Officer) sold 688 shares.
- RICHARD S LEVY has traded it 5 times. They made 0 purchases and 5 sales, selling 10,000 shares.
- WILLIAM JOHN SIBOLD (President and CEO) sold 6,363 shares.
- ROBERT E. WALTERMIRE (Senior VP, Chief Pharma Dev.) has traded it 2 times. They made 0 purchases and 2 sales, selling 3,900 shares.
- FRED b CRAVES 已进行了4次交易。他们进行了0次购买和4次出售,共售出7,000股。
- 首席商务官CAROLE HUNTSMAN卖出了688股。
- RICHARD S LEVY 已进行了5次交易。他们进行了0次购买和5次出售,共售出10,000股。
- 总裁兼首席执行官WILLIAm JOHN SIBOLD卖出6,363股。
- ROBERT E. WALTERMIRE(高级副总裁,首席药物开发员)已经进行了2次交易。他们进行了0次购买和2次销售,出售了3,900股。
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
要跟踪内部交易,请查看Quiver Quantitative的内部交易特斯拉-仪表。
$MDGL Hedge Fund Activity
$MDGL 对冲基金活动
We have seen 130 institutional investors add shares of $MDGL stock to their portfolio, and 168 decrease their positions in their most recent quarter.
我们看到130家机构投资者在最近一个季度将$MDGL股票加入其投资组合,而有168家机构减少了他们的持仓。
Here are some of the largest recent moves:
以下是一些最近最大的交易动态:
- PERCEPTIVE ADVISORS LLC removed 264,600 shares (-100.0%) from their portfolio in Q3 2024
- RA CAPITAL MANAGEMENT, L.P. removed 204,500 shares (-100.0%) from their portfolio in Q2 2024
- BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC removed 196,995 shares (-100.0%) from their portfolio in Q2 2024
- PAULSON & CO. INC. added 192,000 shares (+10.4%) to their portfolio in Q3 2024
- BRAIDWELL LP added 183,818 shares (+inf%) to their portfolio in Q3 2024
- TCG CROSSOVER MANAGEMENT, LLC removed 149,283 shares (-100.0%) from their portfolio in Q3 2024
- STATE STREET CORP added 143,038 shares (+19.2%) to their portfolio in Q3 2024
- PERCEPTIVE ADVISORS LLC在2024年第三季度从其投资组合中减少了264,600股(-100.0%)。
- RA CAPITAL MANAGEMENT, L.P.在2024年第二季度从其投资组合中剔除了204,500股(-100.0%)。
- BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC在2024年第二季度从其投资组合中剔除了196,995股(-100.0%)。
- PAULSON & CO. INC.在2024年第三季度新增了192,000股(+10.4%)至其投资组合中
- BRAIDWELL LP在2024年第三季度新增了183,818股(+inf%)至其投资组合中
- TCG CROSSOVER MANAGEMENT,LLC在2024年第三季度从其投资组合中减少了149,283股(-100.0%)
- STATE STREET CORP在2024年第三季度新增了143,038股(+19.2%)至其投资组合中
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
要追踪对冲基金的股票组合,请查看Quiver Quantitative的机构持股仪表板。
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
本文不构成金融建议。有关Quiver Quantitative的免责声明,请查看更多信息。